The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
88016842 8801684 2 F 20040416 20160715 20120921 20160719 EXP US-ELI_LILLY_AND_COMPANY-US200910007677 ELI LILLY AND CO 52.00 YR F Y 0.00000 20160719 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
88016842 8801684 1 PS ZYPREXA OLANZAPINE 1 5 MG, EACH EVENING Y U 20592 5 MG TABLET QD
88016842 8801684 2 C PAXIL PAROXETINE HYDROCHLORIDE 1 UNK U 0
88016842 8801684 3 C TRILAFON PERPHENAZINE 1 U 0
88016842 8801684 4 C COGENTIN BENZTROPINE MESYLATE 1 U 0
88016842 8801684 5 C VISTARIL HYDROXYZINE PAMOATE 1 U 0
88016842 8801684 6 C GLUCOVANCE GLYBURIDEMETFORMIN HYDROCHLORIDE 1 U 0
88016842 8801684 7 C LASIX FUROSEMIDE 1 U 0
88016842 8801684 8 C LOTREL /01388302/ 2 U 0
88016842 8801684 9 C NORVASC AMLODIPINE BESYLATE 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
88016842 8801684 1 Schizophrenia

Outcome of event

Event ID CASEID OUTC COD
88016842 8801684 HO
88016842 8801684 OT
88016842 8801684 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
88016842 8801684 Acidosis
88016842 8801684 Acute sinusitis
88016842 8801684 Bronchitis
88016842 8801684 Cardiac failure congestive
88016842 8801684 Cardiomyopathy
88016842 8801684 Cerebrovascular accident
88016842 8801684 Chest pain
88016842 8801684 Conjunctivitis
88016842 8801684 Cyst
88016842 8801684 Dental caries
88016842 8801684 Diabetes mellitus
88016842 8801684 Haematocrit increased
88016842 8801684 Haemoglobin increased
88016842 8801684 Hyperglycaemia
88016842 8801684 Hyperlipidaemia
88016842 8801684 Hyponatraemia
88016842 8801684 Hypotension
88016842 8801684 Intestinal obstruction
88016842 8801684 Leukocytosis
88016842 8801684 Nasopharyngitis
88016842 8801684 Neutrophil count increased
88016842 8801684 Sinusitis
88016842 8801684 Urinary tract infection
88016842 8801684 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
88016842 8801684 1 20010430 0